Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies
暂无分享，去创建一个
Hong Wang | H. Rugo | A. Italiano | R. Kelley | A. Nagrial | S. Piha-Paul | A. Hansen | H. Chung | D. Oh | K. Nakagawa | D. Malka | M. Ueno | F. de Braud | T. Doi | A. Varga | S. Krishnan | W. Ros | K. Norwood | A. Nagrial